News & Updates

A systematic review and meta-analysis of 15 studies attest to the efficacy of single-lead electrocardiogram (ECG) smart chest patches and photoplethysmography (PPG)-based smartwatches for atrial fibrillation (AF) detection.

Researchers from Singapore found an elevated risk of venous thromboembolism (VTE) events in individuals with Parkinson’s disease (PD) in a systematic review and meta-analysis of 13 studies.

Adherence to medications contributes to a reduced risk of hospitalization due to cardiovascular disease (CVD) in older people with coronary heart disease (CHD), reports a Vietnam study.

The advent of new lipid-lowering agents, such as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, has led to guideline updates on management of chronic coronary syndrome (CCS) and acute coronary syndrome (ACS). In addition to potent LDL-cholesterol (LDL-C) reduction, alirocumab may mitigate atherosclerotic cardiovascular disease (ASCVD) risk by inducing plaque stabilization and exerting protective vascular effects.